Xometry Inc

XMTR remains in a Stage 2 advancing regime with a bullish medium-term structure, but the active Bullish Exhaustion pattern and overbought, extended price near resistance suggest fatigue. While the long-term uptrend stays intact, near-term execution is not optimal, so entry should be deferred. Ideal engagement will come on a pullback into the rising EMAs or prior support zones, where price can demonstrate acceptance and renewed upside momentum.

• ↑Q1 revenue $151M (+23% YoY) with positive adjusted EBITDA of $0.1M.
• ↑Q2 revenue $163M (+23% YoY) driven by robust marketplace demand.
• ↓Negative earnings yield signals potential overvaluation relative to cash flows.